Results 41 to 50 of about 1,175,648 (153)
Clinical Endocrinology, Volume 105, Issue 4, Page 452-463, October 2026.ABSTRACT Objective Evaluate the effects of osilodrostat short‐ and long‐term treatment on health‐related quality of life (HRQoL) in Cushing's disease. Design LINC 3 and LINC 4 studies (pooled analysis). Patients 185 patients (mean baseline total scores: Cushing's Quality of Life [CushingQoL], 44.0; Beck Depression Inventory II [BDI‐II], 15.6; EuroQol ...
John Newell‐Price +6 more
wiley +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 9543-9551, October 2026.ABSTRACT Aims People with Type 2 diabetes experience higher cardiometabolic risk, and both synthetic glucocorticoids and use of 5α‐reductase inhibitors have been individually linked to increased risk of myocardial infarction. We tested whether the increase in risk is exacerbated by co‐prescription of both drugs.
Haolan Tu +20 more
wiley +1 more source
Past, Present and Future: A Historical Analysis and Reflection of 100 Years of Nursing Leadership
Nursing Inquiry, Volume 33, Issue 4, October 2026.ABSTRACT This paper critically examines the evolution of nursing leadership over the past century, exploring how changing historical, social and professional contexts have influenced styles and their ongoing relevance to contemporary nursing practice.
Sherrie Bolton +4 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 9, September 2026.ABSTRACT This study described a rare case of an 83‐year‐old man diagnosed with drug‐induced skin lesions of bilateral lower extremities after continuous self‐administration with clobetasol propionate ointment for eczema. On admission, his skin was paper‐thin, peeling, dry, bruising, and swollen on both lower extremities.
Jie Chen +4 more
wiley +1 more source
Endocrinology, Diabetes &Metabolism, Volume 9, Issue 5, September 2026.In this population‐based study of 883 women, AMH declined less with age in women with PCOS than in healthy women. Higher AMH may protect older healthy women from T2DM but indicates elevated metabolic risk in younger women with PCOS, supporting its role as a life‐course biomarker for metabolic risk stratification.
Fahimeh Ramezani Tehrani +5 more
wiley +1 more source